AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
May 19, 2025
35599_dirs_2025-05-19_19840743-f7d5-4135-bce4-3e933ba12b8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-05-16
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-16 | Common shares | A | 33334 | — | Acquired | 86921 | Direct |
| 2025-05-16 | Common shares | S | 16667 | $6.78 | Disposed | 70254 | Direct |
Footnotes
F1: Represents shares released from restriction from shares awarded 5-16-2024.
F2: The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain restricted stock units.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20